Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

145
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
145

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermediate filament protein Vimentin propels intrahepatic lipid accumulation in insulin-resistant mice.

The Journal of biological chemistry·2026
Same author

The ULK1-NCOA3 axis restrains de novo lipogenesis and prevents diet-induced steatohepatitis and fibrosis in mice.

The Journal of clinical investigation·2026
Same author

New <i>In Situ</i> Gel Eye Formulation Based on Aristoflex and Xanthan Gum in the Management of Glaucoma Disease: Nonclinical Studies.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2026
Same author

Histoacryl glue injection in walled-off necrosis impression on gastric wall mistaken as gastric varix: an unintended adverse event having therapeutic benefit.

iGIE : innovation, investigation and insights·2026
Same author

Validation of a Gamified Eye-hand Coordination Tool for Post-stroke Upper Limb Assessment Using Tobii EyeX and Leap Motion: A Pilot Study.

Annals of neurosciences·2026
Same author

Functional rescue and AI analysis of a human inactivating GPCR mutation using a small molecule.

EMBO molecular medicine·2026

Related Experiment Video

Updated: Sep 3, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.3K

Liver-Derived S100A6 Propels β-Cell Dysfunction in NAFLD.

Surbhi Dogra1, Debajyoti Das2, Sujay K Maity2

  • 1School of Basic Sciences, Indian Institute of Technology-Mandi.

Diabetes
|July 28, 2022
PubMed
Summary

Elevated S100A6 protein, driven by liver fat accumulation in nonalcoholic fatty liver disease (NAFLD), impairs insulin secretion from pancreatic beta cells, increasing type 2 diabetes risk.

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.1K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.0K

Related Experiment Videos

Last Updated: Sep 3, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.3K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.1K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.0K

Area of Science:

  • Metabolic disease research
  • Hepatology
  • Endocrinology

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is linked to insulin resistance and type 2 diabetes mellitus (T2DM).
  • The precise mechanisms by which liver fat accumulation impairs pancreatic beta-cell function remain unclear.
  • De novo lipogenesis (DNL) is a key process in NAFLD pathogenesis.

Purpose of the Study:

  • To investigate the role of S100A6 in the relationship between NAFLD and beta-cell dysfunction.
  • To identify potential biomarkers for predicting diabetes risk in NAFLD patients.

Main Methods:

  • Measurement of serum S100A6 levels in human NAFLD patients and a mouse model.
  • Assessment of glucose-stimulated insulin secretion (GSIS) and mitochondrial respiration in beta cells.
  • Investigation of S100A6 regulation by carbohydrate response element-binding protein (ChREBP) in the liver.

Main Results:

  • Serum S100A6 levels are elevated in NAFLD and negatively correlate with beta-cell function in humans.
  • S100A6 inhibits GSIS by activating the receptor for advanced glycation end products and reducing mitochondrial respiration.
  • Hepatic S100A6 induction by ChREBP contributes to impaired insulin secretion in NAFLD mice.

Conclusions:

  • S100A6 is identified as a novel hepatokine linking NAFLD to beta-cell dysfunction and T2DM development.
  • Elevated serum S100A6 may serve as a biomarker for identifying NAFLD patients at high risk for T2DM.
  • Targeting S100A6 or its regulatory pathways could offer therapeutic strategies for NAFLD-associated diabetes.